1. Introduction
===============

Globally, respiratory virus infections are responsible for significant morbidity and mortality, especially in children ([@bib16]). The viruses associated with respiratory disease that are well recognized in human populations include influenza viruses, parainfluenza viruses, rhinoviruses, respiratory syncytial viruses, adenoviruses, human coronaviruses, human metapneumoviruses and human bocaviruses. Recently, KI polyomavirus ([@bib1]) and WU polyomavirus ([@bib10]) were identified in respiratory secretions from human patients with acute respiratory tract infection.

Polyomaviruses are small (40--50 nanometers in diameter) DNA viruses belonging to the *Polyomaviridae* family. They are non-enveloped icosahedral particles containing a circular double stranded DNA genome of approximately 5000 base pairs in length. They can infect a number of hosts of various species such as birds, rodents and primates. Four distinct polyomaviruses -- JC (John Cunningham) virus, BK virus, KI (Karolinska Institute) virus and WU (Washington University) virus -- have been reported to infect humans. Both JC virus and BK virus were discovered in 1971 ([@bib9] and [@bib18]) and are genetically closely related to each other. They usually cause asymptomatic infections; yet, they can become oncogenic or induce disease in immunosuppressed or immunocompromised patients ([@bib13], [@bib12], [@bib8]).

Two novel, closely related polyomaviruses (KI and WU) were recently identified in respiratory secretions from children with acute respiratory tract infections ([@bib1] and [@bib10]). Thus, KI and WU polyomaviruses were reported as novel viruses potentially causing respiratory disease in humans. However, both KI and WU polyomaviruses were frequently co-detected with other respiratory viruses. Moreover, a previous study reported that no evidence for an aetiological link between KI or WU polyomavirus infections and respiratory disease ([@bib17]). Therefore, the clinical significance of KI and WU polyomaviruses requires further investigation. This study was aimed at establishing prevalence and clinical association of KI and WU polyomavirus infections in children with respiratory disease in Thailand. Moreover, KI and WU polyomaviruses isolated in Thailand were subjected to genetic and phylogenetic analysis.

2. Materials and methods
========================

2.1. Clinical samples
---------------------

At King Chulalongkorn Memorial Hospital, Thailand, nasopharyngeal suction specimens were collected from 302 hospitalized pediatric patients (age range 5 days to 14 years) with respiratory illness from February 2006 through February 2007. NP suction samples were collected in 1 ml of transport medium with antibiotics (Penicillin G 2 × 10^6^  U/l and Streptomycin 200 mg/l) and stored at −70 °C until tested. The study was approved by the ethics committee of Chulalongkorn University and informed consent was obtained from the patient\'s parents.

2.2. Nucleic acid extraction and cDNA synthesis
-----------------------------------------------

DNA and RNA were extracted using TRI REAGENT^®^ LS (Molecular Research Center, Inc., Cincinnati, OH) and the resulting pellets were dissolved in 20 μl of 8 mM NaOH solution or DEPC-treated water for DNA or RNA, respectively. Reverse transcription (RT) was performed at 37 °C for 2 h using the M-MLV reverse-transcription system (Promega, Madison, WI) consisting of 200 units of M-MLV reverse transcriptase, 5 μl of 5× M-MLV reaction buffer, 5 μl of 10 mM dNTP, 25 units of RNasin^®^ ribonuclease inhibitor, 0.5 μg/μl of random hexamer, 0.5 μg of RNA and nuclease-free water to a final volume of 25 μl.

2.3. Detection of respiratory viruses by PCR amplification
----------------------------------------------------------

PCR amplifications of KI and WU polyomaviruses were performed by using specific primer sets described in previous publications ([@bib1] and [@bib10]). In addition, PCR amplifications of other respiratory viruses including human metapneumovirus, human bocavirus, influenza A virus, influenza B virus, parainfluenza virus, adenovirus and respiratory syncytial virus were performed by using specific primers described in previous reports ([@bib21], [@bib2], [@bib6], [@bib7], [@bib5], [@bib14], [@bib20]). Amplification of the human GAPDH gene served as an internal control of specimen quality and integrity. The limits of detection were approximately 10^3^  copies/μl and 10 copies/μl for conventional PCR and nested PCR, respectively. All specific primers used in this study are summarized in [Table 1](#tbl1){ref-type="table"} .Table 1Primers used for PCR amplification of specific virusesTargetOligo nameSequence (5′ → 3′)PositionGeneProduct size (bp)ReferencesWU polyomavirusWU_925F5′-GCAGGATACAATCCCCAAGGA-3′925--948VP2656Modified from [@bib10]WU_1580R5′-GCTGCATAATGGGGAGTACC-3′1580--1561WU_1331F5′-TGTTACAAATAGCTGCAGGTCAA-3′1331-1353VP2250[@bib10]WU_1580R5′-GCTGCATAATGGGGAGTACC-3′1580--1561  KI polyomavirusKI_1534F5′-ACAAGGCCAAGAAGTCAAGTTC-3′1534--1555VP1329[@bib1]KI_1862R5′-TCACACTCACTAACTTGATTTGG-3′1862--1840KI_1613F5′-CAGTACCACTGTCAGAAGAAAC-3′1613--1634VP1208KI_1821R5′-TTCTGCCAGGCTGTAACATAC-3′1821--1801  Human MetapneumovirusMPVP_F5′-ACGGGGTAGAGAAGAGCTGG-3′389--408N616[@bib21]MPVP_R5′-GCAAAGTTGGGACAGTTGGC-3′1004--985MPVN_F5′-GCATCAACCATAGAAGTGGGAC-3′556--577N259MPVN_R5′-GCATTGTTTGACCGGCCCCA-3′814--795  Human BocavirusHBoV_188F5′-GACCTCTGTAAGTACTATTAC-3′2351--2371NP1354[@bib2]HBoV_542R5′-CTCTGTGTTGACTGAATACAG-3′2704--2684HBoV_VPF25′-TTCAGAATGGTCACCTCTACA-3′3639--3659VP1648[@bib6]HBoV_VPR25′-CTGTGCTTCCGTTTTGTCTTA-3′4286--4266  Influenza A virusFluA_M\_F5′-RGGCCCCCTCAAAGCCGA-3′76--93M1160[@bib7]FluA_M\_R5′-ACTGGGCACGGTGAGYGT-3′235--218  Influenza B virusFluB_M\_F5′-ATGTCGCTGTTTGGAGACACAAT-3′25--47M1295[@bib5]FluB_M\_R5′-TCAGCTAGAATCAGRCCYTTCTT-3′320--301  Parainfluenza virusPara_F5′-GCTAAATACTGTCTTMAHTGGAGAT-3′11254--11278L139[@bib6]Para_R5′-GTAAGGATCACCWACATADAWTGTA-3′11392--11370  AdenovirusAdeno_F5′-GATGGCCACCCCATCGATGMTGC-3′18227--18249L396[@bib14]Adeno_R5′-GCGAACTGCACCAGACCCGGAC-3′18324--18303  Respiratory syncytial virus (type A and B)RSV_AB-F5′-GTCTTACAGCCGTGATTAGG-3′1673--1692N838[@bib20]RSV_AB_R5′-GGGCTTTCTTTGGTTACTTC-3′2510--2491Respiratory syncytial virus (type A)RSV_A\_F5′-GATGTTACGGTGGGGAGTCT-3′1908--1927N343RSV_A\_R5′-GTACACTGTAGTTAATCACA-3′2242--2223Respiratory syncytial virus (type B)RSV_B\_F5′-AATGCTAAGATGGGGAGTTC-3′1905--1923N183RSV_B\_R5′-GAAATTGAGTTAATGACAGC-3′2098--2070  Internal controlGAPDH_F5′-GTGAAGGTCGGAGTCAACGG-3′112--131Human GAPDH492[@bib7]GAPDH_R5′-GTTGTCATGGATGACCTTGGC-3′603--583

The conventional PCR reaction mixture comprised 2 μl of DNA or cDNA, 0.5 μM of each primer, 10 μl of 2.5× Eppendorf MasterMix (Eppendorf, Hamburg, Germany), and nuclease-free water to a final volume of 25 μl. The amplification reactions were performed in a thermal cycler (Eppendorf, Hamburg, Germany) under the following conditions: initial denaturation at 94 °C for 3 min, followed by 40 amplification cycles consisting of 94 °C for 30 s, 50--60 °C (depending on the specific primer pair) for 30 s, and 72 °C for 1 min, and concluded by a final extension at 72 °C for 7 min. After 2% agarose gel electropholysis, the expected amplified products ([Table 1](#tbl1){ref-type="table"}) were stained with ethidium bromide and then visualized under UV transillumination.

2.4. Amplification of complete genome sequences of WU/KI polyomaviruses
-----------------------------------------------------------------------

In order to study the genome characteristics of WU and KI polyomaviruses isolated in Thailand, whole genome sequencing was performed on two specimens of WU polyomaviruses (CU_295 and CU_302) and two specimens of KI polyomaviruses (CU_255 and CU_258). The complete genomes of WU/KI polyomaviruses were amplified directly from clinical samples using four primer pairs to generate overlapping fragments of the circular genome. All primers used for whole genome sequencing were designed from regions conserved among WU and KI polyomaviruses as summarized in [Table 2](#tbl2){ref-type="table"} . The reaction mixture was prepared using the Eppendorf MasterMix (Eppendorf, Hamburg, Germany) as described above. The amplification reactions were performed in a thermal cycler (Eppendorf, Hamburg, Germany) under the following conditions: initial denaturation at 94 °C for 3 min, followed by 40 amplification cycles consisting of 94 °C for 30 s, 55 °C for 30 s, and 72 °C for 2 min, and concluded by a final extension at 72 °C for 7 min. After 2% agarose gel electropholysis, the expected amplified products were purified and subsequently sequenced using 12 primers as summarized in [Table 2](#tbl2){ref-type="table"}.Table 2Conserved primers for whole genome amplification and sequencing of WU/KI polyomavirusesOligo nameSequence (5′ → 3′)Position[a](#tbl2fn1){ref-type="table-fn"}Product (bp)WU/KI_4969FTTGCAGTTTTAAATATAAAGAATTAAG4969--49951395WU/KI_761RACAGTAGYAGCTGCTTCAGATAT761--739WU/KI_1134RGGCAATTCTATTGAACACGTCCT1134--1112WU/KI_989FCCCCCTACYCAGGAATGGCA989--10081560WU/KI_1990RATTWGGWATATCAGGGGGAGCAA1990--1968WU/KI_2548RCCTTCTTTGTCTAAARTGTAGCCTA2548--2524WU/KI_2407FACTRTTGGATGAAAATGGCATTGG2407--24301695WU/KI_2870FGCAAAYTCAGTAAGGCCTATATA2870--2892WU/KI_4101RCATAGAGTTAGTGCTRTTAATAACTT4101--4076WU/KI_3780FTACTAYTGCATTTTTCACACTCTTC3780--38041389WU/KI_4703RTGTGGATAGAGTGYTACTGCTA4703--4682WU/KI_5168RAAGAAGGCAAAATGGATAAAACTTT5168--5144[^1]

2.5. Nucleotide sequencing
--------------------------

For identification of nucleotide sequences, the PCR amplified products were purified using the Perfectprep Gel Cleanup kit (Eppendorf, Hamburg, Germany) according to the manufacturer\'s specifications. The resulting purified DNAs served as templates for DNA sequencing in the ABI PRISM^®^ 310 automated DNA sequencer with the Big Dye Terminator V.3.0 Cycle Sequencing Ready Reaction kit (ABI, Foster City, CA). Determination of the nucleotide sequences were performed in duplicate and analyzed by both direction using forward and reverse primers to ensure that variations of nucleotide sequences were not due to sequencing errors. When a difference was observed, triplicate sequences were determined in order to confirm the consistency of the sequencing result.

2.6. Sequencing analysis and phylogenetic tree construction
-----------------------------------------------------------

Nucleotide sequences were analyzed and assembled using the Lasergene 6 Package^®^ (DNASTAR, Inc., Madison, WI, USA) and BLAST analysis tool (<http://www.ncbi.nlm.gov/BLAST>). Complete genome sequences were prepared and aligned using Clustal W implemented in the BioEdit program (version 7.0.4.1). Phylogenetic trees were constructed by neighbor-joining analysis with the Tamura-Nei model implemented in the MEGA3^©^ program ([@bib15]). All nucleotide sequences of WU/KI polyomavirus obtained from this study were submitted to the GenBank database and assigned accession numbers [EU358745](EU358745)--[EU358769](EU358769) ([Table 3](#tbl3){ref-type="table"} ).Table 3Clinical characteristics of WU/KI polyomavirus positive patientsPatient No.SexAgeDate[a](#tbl3fn1){ref-type="table-fn"} (d/m/y)Hospitalized daysResultCo-infected virusesClinical signs and symptomsAccession numberCU_4M7 months16/02/0615WUAdenovirusSevere bronchopneumonia[EU358745](EU358745)CU_5F3 years22/02/064WU--Pneumonia[EU358746](EU358746)CU_12M1 year08/03/062WU--Pneumonia[EU358747](EU358747)CU_32F3 years13/04/066WUFlu APneumonia[EU358748](EU358748)CU_38F1 year28/04/063WUAdenovirusPneumonia[EU358749](EU358749)CU_50M1 year29/05/0614WU--Pneumonia[EU358750](EU358750)CU_62M1 year16/06/063WU--Pneumonia[EU358751](EU358751)CU_76M2 years10/07/064WU--Pneumonia (congenital musculoskeletal deformities)[EU358752](EU358752)CU_84M3 months14/07/064KI--Pneumonia[EU358762](EU358762)CU_93M5 months31/07/064WURSVPneumonia[EU358753](EU358753)CU_104F9 years27/07/0645 (dead)KIMPVPneumonia, Germinoma of brain[EU358763](EU358763)CU_141M1 year29/08/0612WUAdenovirusPneumonia (gastro-esophageal reflex)[EU358754](EU358754)CU_182F2 years04/10/064WU--Pneumonia, Growth retardation[EU358755](EU358755)CU_187F9 months04/10/065WUAdenovirusCroup[EU358756](EU358756)CU_199M3 years17/10/0610WU--Pneumonia, Down\'s syndrome[EU358757](EU358757)CU_205M1 year17/10/062WUBocavirusAcute brochiolitis[EU358758](EU358758)CU_214M2 years27/10/066WU--Asthmatric bronchitis[EU358759](EU358759)CU_255M1 year17/12/062KI--Acute bronchiolitis[EU358766](EU358766)CU_257F1 year22/12/0614KI--Pneumonia[EU358764](EU358764)CU_258M1 year15/12/0679KI--Pneumonia (cirrhosis)[EU358767](EU358767)CU_262M3 years03/01/073WUFlu APneumonia[EU358760](EU358760)CU_265M1 year10/01/075KIBocavirusNeuroblastoma pneumonia[EU358765](EU358765)CU_276M1 year18/01/078WU--Bronchopneumonia[EU358761](EU358761)CU_295F1 year17/02/073WU--Acute bronchiolitis[EU358768](EU358768)CU_302M1 year28/02/075WU--Pneumonia[EU358769](EU358769)[^2]

2.7. Statistical analysis
-------------------------

Statistical data were analyzed using SPSS for Windows version 11.5 software package. Statistical analyses were performed using Pearson *χ* ^2^ for determination of seasonal distribution of WU and KI polyomaviruses. The results were considered statistically significant at *P*  \< 0.05.

3. Results
==========

3.1. Prevalence of WU polyomavirus in Thailand
----------------------------------------------

PCR amplification and subsequent nucleotide sequencing demonstrated that 19 of the 302 nasopharyngeal suction specimens were positive for WU polyomavirus, amounting to a prevalence of 6.29% in this sample population. Single infection with WU polyomavirus was detected in 11 of the 19 positive cases (57.89%), whereas 8 cases (42.11%) showed evidence of co-infection with other respiratory viruses. Four cases were co-infected with adenovirus, two with influenza A virus, one with respiratory syncytial virus and one with human bocavirus ([Table 3](#tbl3){ref-type="table"}, [Table 4](#tbl4){ref-type="table"} ).Table 4Co-infection of WU/KI polyomavirus with other respiratory virusesPositive cases (% of positive)WU polyomavirusKI polyomavirusSingle infection11 (57.81%)4 (66.67%)  Co-infection with Adenovirus4 (21.05%)0 Influenza A virus2 (10.53%)0 Influenza B virus00 Parainfluenza virus00 Human Metapneumovirus01 (16.67%) Human Bocavirus1 (5.26%)1 (16.67%) Respiratory syncytial virus1 (5.26%)0  Total196

3.2. Prevalence of KI polyomavirus in Thailand
----------------------------------------------

KI polyomavirus was detected in 6 of the 302 respiratory specimens, indicating a prevalence of 1.99% in the Thai population. Single infection with KI polyomavirus was detected in four of six positive specimens (66.67%), whereas the remaining two cases (33.33%) were co-infected with human metapneumovirus and human bocavirus, respectively ([Table 3](#tbl3){ref-type="table"}, [Table 4](#tbl4){ref-type="table"}).

3.3. Clinical presentation in WU/KI polyomavirus positive patients
------------------------------------------------------------------

Patient positive for WU or KI polyomavirus suffered from a wide range of respiratory symptoms including bronchopneumonia, croup, bronchiolitis, bronchitis and pneumonia ([Table 3](#tbl3){ref-type="table"}). Most of the patients (11 of 15) only infected with WU or KI polyomaviruses showed clinical signs associated with pneumonia. However, associations between the presence of WU/KI polyomaviruses and respiratory diseases remain highly speculative due to the lack of comprehensive case control studies. Although WU/KI polyomavirus positive specimens were detected in subjects ranging in age from 3 months to 9 years, the majority were found in approximately 1-year-old babies ([Table 3](#tbl3){ref-type="table"}). There was no significant seasonal variation for WU polyomavirus infection (*P*  = 0.11), but a predominance of infection was detected during the winter months (November--January in Thailand) for KI polyomavirus (*P*  = 0.02), respectively ([Fig. 1](#fig1){ref-type="fig"} ).Fig. 1Seasonal variation and WU/KI polyomavirus infection. Bar graph shows number of WU or KI positive samples as well as total number of clinical specimens collected from 302 pediatric patients with respiratory disease in each month from February 2006 through February 2007.

3.4. Complete genome analysis of WU polyomavirus in Thailand
------------------------------------------------------------

Whole genome sequences of WU polyomaviruses found in Thai patients (isolates CU_295 \[[EU358768](EU358768)\] and CU_302 \[[EU358769](EU358769)\]) were aligned with Australian isolates \[[EF444549](EF444549)--[EF444554](EF444554)\] ([@bib10]). Analysis of WU polyomavirus nucleotide sequences showed 99.6--99.9% similarity among the Thai and Australian isolates. Phylogenetic analysis revealed that WU polyomaviruses isolated in Thailand (CU_295 and CU_302) were closely related to the reference strain of WU polyomavirus \[[NC_009539](NC_009539) or [EF444549](EF444549)\] ([Fig. 2](#fig2){ref-type="fig"}A). Additionally, there were numerous variations of the nucleotide sequences within non-coding regions including nucleotide positions 4, 32, 286, 2797, 4522 and 4559 ([Table 5](#tbl5){ref-type="table"} ). Furthermore, analysis of deduced amino acids within the coding sequences revealed that several variations had occurred within coding sequences including the VP2 protein (amino acid positions 239, 250, 284 and 356), VP1 protein (amino acid position 79), and Large T Antigen (amino acid positions 360, 378, 440, 520 and 594) as shown in [Table 5](#tbl5){ref-type="table"}.Fig. 2Phylogenetic tree constructed by neighbor-joining analysis with the Tamura-Nei model implemented in the MEGA3^©^ program (version 3.1). Nodal confidence values indicate the results of bootstrap re-sampling (*n* = 1000). (A) Phylogenetic tree of whole genome sequences of WU polyomaviruses. (B) Phylogenetic tree of whole genome sequences of KI polyomaviruses.Table 5Variations of nucleotide sequences within non-coding regions and amino acid sequences within coding regions of WU polyomavirusesAccession no./isolate nameVariations of nucleotide sequences in non-coding regionsVariation of deduced amino acid in coding sequences432286279745224559VP2VP1LTAg23925028425679360378440520594[NC_009539](NC_009539)/WU Ref straintgcaatEEDTTDDVGI[EF444549](EF444549)/WU strain B0tgcaatEEDTTDDVGI[EF444550](EF444550)/WU strain S1tgcagtEQDTTDDVGL[EF444551](EF444551)/WU strain S2tgcagtEQDTTDDVEL[EF444552](EF444552)/WU strain S3tgctgtEQDTTGDVGL[EF444553](EF444553)/WU strain S4tccagtEQDTTDDVGL[EF444554](EF444554)/WU strain S5cgcagtEQHTTDGIGL[EU358768](EU358768)/WU Thailand CU_295tgcagtEEDTTDDVGI[EU358769](EU358769)/WU Thailand CU_302tggagaQEDIGDDVGI

3.5. Complete genome analysis of KI polyomavirus in Thailand
------------------------------------------------------------

The complete genome sequences of KI polyomaviruses isolated from Thai patients (isolates CU_255 \[[EU358766](EU358766)\] and CU_258 \[[EU358767](EU358767)\]) were aligned with Swedish sequences \[[EF127906](EF127906)--[EF127908](EF127908)\] ([@bib1]) and Queensland sequences \[[EF520287](EF520287)--[EF520289](EF520289)\] ([@bib4]). Nucleotide sequence analysis of KI polyomaviruses revealed 99.4--99.9% identity among the Thai, Queensland and Swedish isolates. Phylogenetic analysis showed that one of the KI polyomavirus isolated from Thailand (CU_258) was closely related to the reference strain of KI polyomavirus \[[NC_009238](NC_009238) or [EF127906](EF127906)\] whereas the second one (CU_255) was more closely associated with KI polyomavirus isolated from Queensland (isolate Brisbane 001 \[[EF520287](EF520287)\]) ([Fig. 2](#fig2){ref-type="fig"}B). The latter similarity was largely due to a 10 nucleotide insertion (AGGCGCTGCG) at positions 60--69 within the non-coding region which the Thai isolate CU_255 and Queensland isolate Brisbane 001 shared ([Table 6](#tbl6){ref-type="table"} ). Moreover, there were several variations of the nucleotide sequences within non-coding regions as for example, at nucleotide positions 76, 107, 110, 233 and 4656 ([Table 6](#tbl6){ref-type="table"}). Analysis of deduced amino acids within the coding sequences showed a variety of variations within coding sequences for the VP2 protein (amino acid positions 246 and 316), the VP1 protein (amino acid positions 181, 267 and 368), the Large T Antigen (amino acid positions 124, 199, 337, 365 and 494) and the small T Antigen (STAg) (amino acid position 104) as shown in [Table 6](#tbl6){ref-type="table"}.Table 6Variations of nucleotide sequences within non-coding regions and amino acid sequences within coding regions of KI polyomavirusesAccession no./isolate nameVariations of nucleotide sequences in non-coding regionsVariation of deduced amino acid in coding sequences60761071102334656VP2VP1LTAgSTAg246316181267368124199337365494104[NC_009238](NC_009238)/KI Ref strain--tttcaTPKQAEYVLQD[EF127906](EF127906)/KI Stockholm 60--tttcaTPKQAEYVLQD[EF127907](EF127907)/KI Stockholm 350--ccgatSPKQTEYVVQE[EF127908](EF127908)/KI Stockholm 380--acgaaTPKQAEYVVHD[EF520287](EF520287)/KI isolate Brisbane 001aggcgctgcgtcaatSSRQAEYLVQE[EF520288](EF520288)/KI isolate Brisbane 002--tttcaTPKQAEYVLQD[EF520289](EF520289)/KI isolate Brisbane 003--tagatSPKHAEYVVQE[EU358766](EU358766)/KI Thailand CU_255aggcgctgcgtcaatSSRQAKHLVQE[EU358767](EU358767)/KI Thailand CU_258--tttcaTPKQAEYVLQD

3.6. Characterization of the non-coding regulatory region
---------------------------------------------------------

Alignment of the non-coding regulatory regions of WU and KI polyomaviruses revealed AT-rich sequences on the downstream of the putative replication origin. Both Thai WU polyomavirus isolates (CU_295 and CU_302) contained an A/T rich region (TTTTTTTTATTATAATAA) common to the Australian isolates \[[EF444549](EF444549)--[EF444554](EF444554)\] whereas both Thai KI polyomavirus isolates (CU_255 and CU_258) contained an A/T rich region (TTTTTTTCTATATTACA) similar to the Swedish sequences \[[EF127906](EF127906)--[EF127908](EF127908)\] and the Queensland sequences \[[EF520287](EF520287)--[EF520289](EF520289)\]. The origin of replication of WU/KI polyomaviruses contains three potential pentanucleotide Large T Antigen (LTAg) binding sites, as opposed to the four found in most polyomaviruses. Two of the LTAg binding sites have the typical sequence "GAGGC" found in all WU/KI polymaviruses analyzed, except for the Australian WU polyomavirus strain S5 \[[EF444554](EF444554)\] that contains "GGGGC" at the second LTAg binding site. The third consensus LTAg binding site found in all isolates of WU polyomaviruses has the sequence "GCCTC" whereas all isolates of KI polyomaviruses display the sequence "GCCCC".

3.7. Characterization of the Large T Antigen
--------------------------------------------

Analysis of the deduced amino acid sequences of the Large T Antigen revealed domains common to both WU and KI polyomaviruses, including the DnaJ domain, Rb binding domain, zinc finger motif and ATPase-p53 binding domain. All WU/KI polyomaviruses analyzed contained the DnaJ domain at the N terminus with the highly conserved hexapeptide motif "HPDKGG" (amino acid positions 42--47) and the Rb binding domain "LRCNE" at amino acid positions 108--113. The zinc finger motif was found in WU polyomaviruses at amino acid residues C321, C324, H336 and H339 whereas KI polyomaviruses displayed it at amino acid residues C312, C315, H327 and H331 of the LTAg protein. Conserved motifs "GPINSGKT" (amino acid positions 443--450) and "GSVKVNLE" (amino acid positions 520--527) were detected in all WU polyomaviruses analyzed whereas the motifs "GPINSGKT" (amino acid positions 436--443) and "GCVEVNLE" (amino acid positions 513--520) were found in all KI polyomaviruses analyzed in this study ([@bib19]).

4. Discussion
=============

Resulting from this research, we present here preliminary data on the role of WU/KI polyomaviruses as potential respiratory pathogens in Thai pediatric patients. The prevalence of WU polyomavirus in Thailand (6.29%) was higher than that reported in Australia (4.5%) ([@bib3]), the United States (1.2%) ([@bib10]) and United Kingdom (1%) ([@bib17]) but comparable to the prevalence reported in a previous study from South Korea (7%) ([@bib11]). This may be due to particular racial predispositions or different geographical distributions of the virus. In contrast, the incidence of KI polyomavirus infection in Thailand (1.99%) was comparable to that established in Sweden (1%) ([@bib1]), Australia (2.6%) ([@bib3]) and the United Kingdom (1.4%) ([@bib17]).

WU polyomavirus infection does not appear subjected to significant seasonal variation; yet, a predominance of infection was detected during the winter months for KI polyomavirus. These findings were not in perfect agreement with previous studies conducted in Australia ([@bib4], [@bib3]) which reported no apparent seasonal variation for KI polyomavirus, but a predominance of infection with WU polyomavirus during late winter to early summer. This discrepancy may be due to seasonal differences in each country.

The genome of WU (5229 bp in length) and KI (5040 bp in length) polyomaviruses comprises an early coding region on one strand for the Small T Antigen and the Large T Antigen, and a late coding region on the opposite strand for the 3 capsid proteins VP1, VP2, and VP3. These two regions are separated by a regulatory non-coding region that contains typical polyomavirus characteristics ([@bib1] and [@bib10]). Based on complete genome analysis, the WU/KI polyomaviruses isolated from Thai patients were closely related to the isolates described in previous reports ([@bib10], [@bib1] and [@bib4]). This may be due to the fact that both WU and KI polyomaviruses are DNA viruses which are less error prone in the DNA replication process. However, there were numerous nucleotide variations within the non-coding regulatory regions as well as several non-synonymous mutations within coding regions.

No other respiratory virus was detected in 57.81% of the WU-positive specimens and 66.67% of the KI-positive specimens in our study, hinting at an association between WU/KI polyomaviruses and respiratory disease. However, these viruses may not be the causative agents of clinical respiratory disease and their presence in the respiratory tract may simply reflect their mode of transmission similar to other polyomaviruses in humans such as JCV and BKV. Nevertheless, most known human viruses are pathogenic in certain conditions and thus, novel viruses must be considered as potential pathogens. Various degrees of clinical symptoms ranging from asymptomatic to mild and severe illness depend on several factors, such as the host\'s immune status and age, the virus strain, viral load and mode of transmission. The 10-nucleotide insertion and several nucleotide sequence variations within non-coding regulatory regions as well as various non-synonymous mutations within the coding regions should be taken into consideration as factors potentially involved in the pathogenesis of these novel viruses. The difficulty with persisting viruses is that they are often discovered out their symptomatic context, so that judging the association of WU/KI polyomavirus infections with a particular disease will be challenging and require further extensive case control investigations.
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[^1]: Position based on nucleotide sequence of WU polyomavirus ([NC_009539](NC_009539)).

[^2]: Date of specimen collection.
